Skip to main content
Top
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Research article

Worldwide Argus II implantation: recommendations to optimize patient outcomes

Authors: Devon H. Ghodasra, Adrienne Chen, J. Fernando Arevalo, David G. Birch, Kari Branham, Brian Coley, Gislin Dagnelie, Eugene de Juan, Robert G. Devenyi, Jessy D. Dorn, Andy Fisher, Duane R. Geruschat, Ninel Z. Gregori, Robert J. Greenberg, Paul Hahn, Allen C. Ho, Ashley Howson, Suber S. Huang, Raymond Iezzi, Naheed Khan, Byron L. Lam, Jennifer I. Lim, Kirsten G. Locke, Michelle Markowitz, Anne-Marie Ripley, Mark Rankin, Hannah Schimitzek, Fay Tripp, James D. Weiland, Jiong Yan, David N. Zacks, K. Thiran Jayasundera

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

A position paper based on the collective experiences of Argus II Retinal Prosthesis System investigators to review strategies to optimize outcomes in patients with retinitis pigmentosa undergoing retinal prosthesis implantation.

Methods

Retinal surgeons, device programmers, and rehabilitation specialists from Europe, Canada, Middle East, and the United States were convened to the first international Argus II Investigator Meeting held in Ann Arbor, MI in March 2015. The recommendations from the collective experiences were collected. Factors associated with successful outcomes were determined.

Results

Factors leading to successful outcomes begin with appropriate patient selection, expectation counseling, and preoperative retinal assessment. Challenges to surgical implantation include presence of staphyloma and inadequate Tenon’s capsule or conjunctiva. Modified surgical technique may reduce risks of complications such as hypotony and conjunctival erosion. Rehabilitation efforts and correlation with validated outcome measures following implantation are critical.

Conclusions

Bringing together Argus II investigators allowed the identification of strategies to optimize patient outcomes. Establishing an on-line collaborative network will foster coordinated research efforts to advance outcome assessment and rehabilitation strategies.
Literature
4.
go back to reference da Cruz L, Coley BF, Dorn J, et al. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br J Ophthalmol. 2013;97(5):632–6.CrossRefPubMedPubMedCentral da Cruz L, Coley BF, Dorn J, et al. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss. Br J Ophthalmol. 2013;97(5):632–6.CrossRefPubMedPubMedCentral
5.
go back to reference Kotecha A, Zhong J, Stewart D, da Cruz L. The Argus II prosthesis facilitates reaching and grasping tasks: a case series. BMC Ophthalmol. 2014;14(71):1–8. Kotecha A, Zhong J, Stewart D, da Cruz L. The Argus II prosthesis facilitates reaching and grasping tasks: a case series. BMC Ophthalmol. 2014;14(71):1–8.
6.
go back to reference Barry MP, Dagnelie G. Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements. Investig Ophthalmol Vis Sci. 2012;53(9):5095–101.CrossRef Barry MP, Dagnelie G. Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements. Investig Ophthalmol Vis Sci. 2012;53(9):5095–101.CrossRef
7.
go back to reference Humayun MS, Dorn JD, Da Cruz L, et al. Interim results from the international trial of second sight’s visual prosthesis. Ophthalmology. 2012;119(4):779–88.CrossRefPubMedPubMedCentral Humayun MS, Dorn JD, Da Cruz L, et al. Interim results from the international trial of second sight’s visual prosthesis. Ophthalmology. 2012;119(4):779–88.CrossRefPubMedPubMedCentral
8.
go back to reference Ahuja AK, Dorn JD, Caspi A, et al. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol. 2011;95(4):539–43.CrossRefPubMed Ahuja AK, Dorn JD, Caspi A, et al. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol. 2011;95(4):539–43.CrossRefPubMed
9.
go back to reference Greenberg RJ, Humayun MS, da Cruz L, et al. Five-year data from the Argus II Retinal Prosthesis System. ARVO 2015 E-abstract 754. Greenberg RJ, Humayun MS, da Cruz L, et al. Five-year data from the Argus II Retinal Prosthesis System. ARVO 2015 E-abstract 754.
10.
go back to reference Vaidya A, Borgonovi E, Taylor RS, et al. The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. BMC Ophthalmol. 2014;14:49.CrossRefPubMedPubMedCentral Vaidya A, Borgonovi E, Taylor RS, et al. The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients. BMC Ophthalmol. 2014;14:49.CrossRefPubMedPubMedCentral
11.
go back to reference Black J, Hickson L, Black B. Defining and evaluating success in paediatric cochlear implantation - An exploratory study. Int J Pediatr Otorhinolaryngol. 2012;76(9):1317–26.CrossRefPubMed Black J, Hickson L, Black B. Defining and evaluating success in paediatric cochlear implantation - An exploratory study. Int J Pediatr Otorhinolaryngol. 2012;76(9):1317–26.CrossRefPubMed
12.
go back to reference Soman UG, Kan D, Tharpe AM. Rehabilitation and educational considerations for children with cochlear implants. Otolaryngol Clin North Am. 2012;45(1):141–53.CrossRefPubMed Soman UG, Kan D, Tharpe AM. Rehabilitation and educational considerations for children with cochlear implants. Otolaryngol Clin North Am. 2012;45(1):141–53.CrossRefPubMed
14.
go back to reference Ahuja a K, Yeoh J, Dorn JD, et al. Factors Affecting Perceptual Threshold in Argus II Retinal Prosthesis Subjects. Transl Vis Sci Technol. 2013;2(4):1.CrossRefPubMedPubMedCentral Ahuja a K, Yeoh J, Dorn JD, et al. Factors Affecting Perceptual Threshold in Argus II Retinal Prosthesis Subjects. Transl Vis Sci Technol. 2013;2(4):1.CrossRefPubMedPubMedCentral
15.
go back to reference Jensen RJ, Rizzo JF, Ziv OR, Grumet A, Wyatt J. Thresholds for activation of rabbit retinal ganglion cells with an ultrafine, extracellular microelectrode. Investig Ophthalmol Vis Sci. 2003;44(8):3533–43.CrossRef Jensen RJ, Rizzo JF, Ziv OR, Grumet A, Wyatt J. Thresholds for activation of rabbit retinal ganglion cells with an ultrafine, extracellular microelectrode. Investig Ophthalmol Vis Sci. 2003;44(8):3533–43.CrossRef
16.
go back to reference Ziv OR, Rizzo JF, Jensen RJ. In vitro activation of retinal cells: estimating location of stimulated cell by using a mathematical model. J Neural Eng. 2005;2(1):S5–S15.CrossRefPubMed Ziv OR, Rizzo JF, Jensen RJ. In vitro activation of retinal cells: estimating location of stimulated cell by using a mathematical model. J Neural Eng. 2005;2(1):S5–S15.CrossRefPubMed
18.
go back to reference Aleman TS, Cideciyan AV, Sumaroka A, et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Investig Ophthalmol Vis Sci. 2007;48(10):4759–65.CrossRef Aleman TS, Cideciyan AV, Sumaroka A, et al. Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations. Investig Ophthalmol Vis Sci. 2007;48(10):4759–65.CrossRef
19.
go back to reference Rizzo S, Belting C, Cinelli L, et al. The Argus II retinal prosthesis: 12-month outcomes from a single-study center. Am J Ophthalmol. 2014;157(6):1282–90.CrossRefPubMed Rizzo S, Belting C, Cinelli L, et al. The Argus II retinal prosthesis: 12-month outcomes from a single-study center. Am J Ophthalmol. 2014;157(6):1282–90.CrossRefPubMed
20.
go back to reference Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Three-Year Follow-up of the Tube Versus Trabeculectomy Study. Am J Ophthalmol. 2009;148(5):670–84.CrossRefPubMed Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Three-Year Follow-up of the Tube Versus Trabeculectomy Study. Am J Ophthalmol. 2009;148(5):670–84.CrossRefPubMed
21.
go back to reference Humayun MS, Dorn JD, Ahuja AK, et al. Preliminary 6 month results from the Argus II epiretinal prosthesis feasibility study. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4566–8.PubMedPubMedCentral Humayun MS, Dorn JD, Ahuja AK, et al. Preliminary 6 month results from the Argus II epiretinal prosthesis feasibility study. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4566–8.PubMedPubMedCentral
22.
go back to reference Geruschat DR, Flax M, Tanna N, et al. FLORATM: Phase I development of a functional vision assessment for prosthetic vision users. Clin Exp Optom. 2015;98(4):342–7.CrossRefPubMedPubMedCentral Geruschat DR, Flax M, Tanna N, et al. FLORATM: Phase I development of a functional vision assessment for prosthetic vision users. Clin Exp Optom. 2015;98(4):342–7.CrossRefPubMedPubMedCentral
23.
go back to reference Dagnelie G, Jeter PE, Adeyemo K, Rozanski C, Nkodo A-F, Massof RW. Psychometric properties of the PLoVR ultra-low vision (ULV) questionnaire. IOVS. 2014;55:E - Abstract 2150. Dagnelie G, Jeter PE, Adeyemo K, Rozanski C, Nkodo A-F, Massof RW. Psychometric properties of the PLoVR ultra-low vision (ULV) questionnaire. IOVS. 2014;55:E - Abstract 2150.
24.
go back to reference Dagnelie G, Barry MP, Adeyemo O, Jeter PE, Massof RW. Twenty Questions: An adaptive version of the PLoVR ultra-low vision (ULV) questionnaire. IOVS. 2015;56:E - Abstract 497. Dagnelie G, Barry MP, Adeyemo O, Jeter PE, Massof RW. Twenty Questions: An adaptive version of the PLoVR ultra-low vision (ULV) questionnaire. IOVS. 2015;56:E - Abstract 497.
Metadata
Title
Worldwide Argus II implantation: recommendations to optimize patient outcomes
Authors
Devon H. Ghodasra
Adrienne Chen
J. Fernando Arevalo
David G. Birch
Kari Branham
Brian Coley
Gislin Dagnelie
Eugene de Juan
Robert G. Devenyi
Jessy D. Dorn
Andy Fisher
Duane R. Geruschat
Ninel Z. Gregori
Robert J. Greenberg
Paul Hahn
Allen C. Ho
Ashley Howson
Suber S. Huang
Raymond Iezzi
Naheed Khan
Byron L. Lam
Jennifer I. Lim
Kirsten G. Locke
Michelle Markowitz
Anne-Marie Ripley
Mark Rankin
Hannah Schimitzek
Fay Tripp
James D. Weiland
Jiong Yan
David N. Zacks
K. Thiran Jayasundera
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0225-1

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue